Viewing Study NCT00328120


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT00328120
Status: COMPLETED
Last Update Posted: 2010-11-17
First Post: 2006-05-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module